title: Therapeutic hypothermia after nonshockable cardiac arrest: the HYPERION multicenter, randomized, controlled, assessor-blinded, superiority trial.
abstract: BACKGROUND
  Meta-analyses of nonrandomized studies have provided conflicting data on therapeutic hypothermia, or targeted temperature management (TTM), at 33°C in patients successfully resuscitated after nonshockable cardiac arrest. Nevertheless, the latest recommendations issued by the International Liaison Committee on Resuscitation and by the European Resuscitation Council recommend therapeutic hypothermia. New data are available on the adverse effects of therapeutic hypothermia, notably infectious complications. The risk/benefit ratio of therapeutic hypothermia after nonshockable cardiac arrest is unclear.
  
  
  METHODS
  HYPERION is a multicenter (22 French ICUs) trial with blinded outcome assessment in which 584 patients with successfully resuscitated nonshockable cardiac arrest are allocated at random to either TTM between 32.5 and 33.5°C (therapeutic hypothermia) or TTM between 36.5 and 37.5°C (therapeutic normothermia) for 24 hours. Both groups are managed with therapeutic normothermia for the next 24 hours. TTM is achieved using locally available equipment. The primary outcome is day-90 neurological status assessed by the Cerebral Performance Categories (CPC) Scale with dichotomization of the results (1 + 2 versus 3 + 4 + 5). The primary outcome is assessed by a blinded psychologist during a semi-structured telephone interview of the patient or next of kin. Secondary outcomes are day-90 mortality, hospital mortality, severe adverse events, infections, and neurocognitive performance. The planned sample size of 584 patients will enable us to detect a 9% absolute difference in day-90 neurological status with 80% power, assuming a 14% event rate in the control group and a two-sided Type 1 error rate of 4.9%. Two interim analyses will be performed, after inclusion of 200 and 400 patients, respectively.
  
  
  CONCLUSIONS
  The HYPERION trial is a multicenter, randomized, controlled, assessor-blinded, superiority trial that may provide an answer to an issue of everyday relevance, namely, whether TTM is beneficial in comatose patients resuscitated after nonshockable cardiac arrest. Furthermore, it will provide new data on the tolerance and adverse events (especially infectious complications) of TTM at 32.5-33.5°C.
  
  
  BACKGROUND
  ClinicalTrials.gov: NCT01994772 .
authors.affiliation: Medical-Surgical Intensive Care Unit, District Hospital Center, La Roche-sur-Yon, France. jean-baptiste.lascarrou@chd-vendee.fr.
authors.forename: Jean Baptiste
authors.initials: JB
authors.lastname: Lascarrou
authors.affiliation: Medical Intensive Care Unit, University Hospital Center, University of Strasbourg, Strasbourg, France. ferhat.meziani@chru-strasbourg.fr.
authors.forename: Ferhat
authors.initials: F
authors.lastname: Meziani
authors.affiliation: INSERM CIC1415, CHRU de Tours, Tours, France. amelie.legouge@univ-tours.fr.|Université François-Rabelais de Tours, PRES Centre-Val de Loire Université, Tours, France. amelie.legouge@univ-tours.fr.
authors.forename: Amélie
authors.initials: A
authors.lastname: Le Gouge
authors.affiliation: Medical Intensive Care Unit, Regional Hospital Center, Orleans, France. thierry.boulain@chr-orleans.fr.
authors.forename: Thierry
authors.initials: T
authors.lastname: Boulain
authors.affiliation: Medical-Surgical intensive Care Unit, General Hospital Center, Saint Brieuc, France. jerome.bousser@ch-stbrieuc.fr.
authors.forename: Jérôme
authors.initials: J
authors.lastname: Bousser
authors.affiliation: Medical Intensive Care Unit, South Brittany General Hospital Center, Lorient, France. belliardguillaume@orange.fr.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Belliard
authors.affiliation: Medical Intensive Care Unit, University Hospital Center, Angers, France. PiAsfar@chu-angers.fr.
authors.forename: Pierre
authors.initials: P
authors.lastname: Asfar
authors.affiliation: Medical Intensive Care Unit, University Hospital Center, Poitiers, France. Jean-Pierre.FRAT@chu-poitiers.fr.
authors.forename: Jean Pierre
authors.initials: JP
authors.lastname: Frat
authors.affiliation: Medical Intensive Care Unit, University Hospital Center, Tours, France. pierre-francois.dequin@univ-tours.fr.
authors.forename: Pierre François
authors.initials: PF
authors.lastname: Dequin
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Saint Malo, France. jp.gouello@ch-stmalo.fr.
authors.forename: Jean Paul
authors.initials: JP
authors.lastname: Gouello
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Rodez, France. a.delahaye@ch-rodez.fr.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Delahaye
authors.affiliation: Medical Intensive Care Unit, University Hospital Center, Clermond-Ferrand, France. aait_hssain@chu-clermontferrand.fr.
authors.forename: Ali Ait
authors.initials: AA
authors.lastname: Hssain
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Roanne, France. jean-charles.chakarian@ch-roanne.fr.
authors.forename: Jean Charles
authors.initials: JC
authors.lastname: Chakarian
authors.affiliation: Medical-Surgical Intensive Care Unit, University Hospital Center, Limoges, France. nicolas.pichon@chu-limoges.fr.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Pichon
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Angouleme, France. arnaud.desachy@ch-angouleme.fr.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Desachy
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Montauban, France. f.bellec@ch-montauban.fr.
authors.forename: Fréderic
authors.initials: F
authors.lastname: Bellec
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Lens, France. dthevenin@ch-lens.fr.
authors.forename: Didier
authors.initials: D
authors.lastname: Thevenin
authors.affiliation: Medical Intensive Care Unit, University Hospital Center, Dijon, France. jean-pierre.quenot@chu-dijon.fr.
authors.forename: Jean Pierre
authors.initials: JP
authors.lastname: Quenot
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Annecy, France. msirodot@ch-annecygenevois.fr.
authors.forename: Michel
authors.initials: M
authors.lastname: Sirodot
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Saint Nazaire, France. f.labadie@ch-saintnazaire.fr.
authors.forename: François
authors.initials: F
authors.lastname: Labadie
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Argenteuil, France. gaetan.plantefeve@ch-argenteuil.fr.
authors.forename: Gaétan
authors.initials: G
authors.lastname: Plantefeve
authors.affiliation: Medical-Surgical Intensive Care Unit, General Hospital Center, Le Mans, France. dvivier@ch-lemans.fr.
authors.forename: Dominique
authors.initials: D
authors.lastname: Vivier
authors.affiliation: Medical Intensive Care Unit, University Hospital Center, Lille, France. patrick.girardie@chru-lille.fr.
authors.forename: Patrick
authors.initials: P
authors.lastname: Girardie
authors.affiliation: INSERM CIC1415, CHRU de Tours, Tours, France. bruno.giraudeau@univ-tours.fr.|Université François-Rabelais de Tours, PRES Centre-Val de Loire Université, Tours, France. bruno.giraudeau@univ-tours.fr.
authors.forename: Bruno
authors.initials: B
authors.lastname: Giraudeau
authors.affiliation: Medical-Surgical Intensive Care Unit, District Hospital Center, La Roche-sur-Yon, France. jean.reignier@chd-vendee.fr.
authors.forename: Jean
authors.initials: J
authors.lastname: Reignier
mesh_terms: D016887:Cardiopulmonary Resuscitation / Q000379:methods*; D005602:France; D015600:Glasgow Coma Scale; D006801:Humans; D007036:Hypothermia, Induced / Q000379:methods*; D009422:Nervous System Diseases / Q000517:prevention & control*; D058687:Out-of-Hospital Cardiac Arrest / Q000628:therapy*; D012107:Research Design; D016896:Treatment Outcome